The invention provides a pigment composition comprising anthocyanic vacuolar inclusions or AVIs from a plant, and an acceptable carrier. The invention also provides methods for coloring products with the pigment composition, and products comprising the pigment composition or AVIs.

Suggested is a pharmaceutical composition comprising valerian extracts or their derivatives that is particularly useful for affecting the sebaceous gland metabolism by exerting a relevant activity as regulator of sebum production (sebogenesis) and the subcutis adipocytes metabolism by regulating adipogenesis.

The present invention provides peptoid polymers capable of reducing or inhibiting the formation of ice crystals at sub 0 C. temperatures. Also provided are peptoid-peptide hybrids comprising the peptoid polymers provided herein. The peptoid polymers and peptoid-peptide hybrids provided herein are useful for making cryoprotectant solutions. The peptoid polymers, peptoid-peptide hybrids, and cryoprotectant solutions provided herein are useful for making antifreeze solutions, frozen food products, and cosmetic care products. Also provided herein are methods for preserving a tissue, an organ, a cell, or a biological macromolecule using the compositions described herein.

The present invention provides peptoid polymers capable of reducing or inhibiting the formation of ice crystals at sub 0 C. temperatures. Also provided are peptoid-peptide hybrids comprising the peptoid polymers provided herein. The peptoid polymers and peptoid-peptide hybrids provided herein are useful for making cryoprotectant solutions. The peptoid polymers, peptoid-peptide hybrids, and cryoprotectant solutions provided herein are useful for making antifreeze solutions, frozen food products, and cosmetic care products. Also provided herein are methods for preserving a tissue, an organ, a cell, or a biological macromolecule using the compositions described herein.

A cosmetic composition comprising a cosmetically active ingredient in a cosmetically acceptable medium, wherein the cosmetic composition contains a silicone composition comprising (A) a hydrophobic organopolysiloxane fluid having a surface tension of from 15 to 40 mN/m and (B) a finely divided solid hydrophobic filler dispersed in the organopolysiloxane fluid (A).

A cosmetic composition comprising a cosmetically active ingredient in a cosmetically acceptable medium, wherein the cosmetic composition contains a silicone composition comprising (A) a hydrophobic organopolysiloxane fluid having a surface tension of from 15 to 40 mN/m and (B) a finely divided solid hydrophobic filler dispersed in the organopolysiloxane fluid (A).

The invention described herein relates to a therapeutic, moisturizing coating composition for elastomeric articles which is applied directly onto the skin-contacting surface of the article as part of the manufacturing process. The coating composition is thermally stable and subsequently hydrates when contacted with a moisturized skin surface to convert into a liquid lotion form during wearing of the article. The coating composition provides therapeutic benefits to the wearer's skin as a result of wearing the article, such as improved skin moisturization, softness of feel, improved skin elasticity and firmness, and reduced redness and irritation. The invention is particularly useful in medical gloves, including examination and surgical gloves.

Disclosed herein is a method for reducing menopausal symptoms. The method may comprise preparing a topical formulation of hops extract, and administering the topical formulation on to a part of skin. Moreover, preparing the topical formulation of hops extract may include preparing the hops extract, encapsulating the hops extract in cyclodextrin to form hops nanoparticles, and dispersing the hops nanoparticles with a concentration between 5 and 15 percent by weight of the formulation in an ointment-based excipient to form the topical formulation of hops extract.

Disclosed herein is a method for reducing menopausal symptoms. The method may comprise preparing a topical formulation of hops extract, and administering the topical formulation on to a part of skin. Moreover, preparing the topical formulation of hops extract may include preparing the hops extract, encapsulating the hops extract in cyclodextrin to form hops nanoparticles, and dispersing the hops nanoparticles with a concentration between 5 and 15 percent by weight of the formulation in an ointment-based excipient to form the topical formulation of hops extract.

The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture.